Pulse Biosciences PLSE
NASDAQ PLSE
$47.90 -1.93 (-3.87%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pulse Biosciences (PLSE) Asset Writedowns and Impairment (2022)

Updated

Pulse Biosciences (PLSE) reported Asset Writedowns and Impairment of $1.11 million for Q4 2022.

Analysis

Pulse Biosciences (PLSE) Asset Writedowns and Impairment (2022) Analysis & Trends

For FY2022, Pulse Biosciences posted Asset Writedowns and Impairment of $8.48 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Pulse Biosciences 3.39 Bn 3.39 Bn 161,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.11 Mn
API Access

Pulse Biosciences Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=PLSE&period=max&api_key=YOUR_API_KEY